Breaking the Pattern: Frontal Fibrosing Alopecia in Men, a Case Series

    Amani Khan, Julian Pearce, Emma Amoafo, Archana Rao
    TLDR Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.
    This case series highlights two unusual instances of frontal fibrosing alopecia (FFA) in men, a condition typically seen in postmenopausal White women. The first case involved a 51-year-old White man who developed FFA following COVID-19 vaccination, with symptoms including scarring alopecia and perifollicular erythema. His son also developed oral lichen planus post-vaccination, suggesting a possible immune-mediated response. The second case was a 44-year-old South Asian man with a misdiagnosed facial rash, later confirmed as FFA with prominent facial papules. These cases underscore the rarity of FFA in men, its potential link to immune triggers like vaccines, and the need for further research into its genetic and environmental causes. A 2023 study identified two genes associated with male FFA, distinct from those in women, indicating different pathogenesis and potential treatment strategies.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 671 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      by nkrata in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community can someone help me identify these pls

      in Treatment 3 months ago
      The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  120 upvotes 4 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 1 year ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

    Related Research

    1 / 1 results